Inhibition of c-Kit, VEGFR-2 (KDR), and ABCG2 by analogues of OSI-930

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 21, 2011, Pages 6495-6499

  Patel, Jay P ^a   Kuang, Ye Hong ^a,b   Chen, Zhe Sheng ^a   Korlipara, Vijaya L ^a  

^a ST JOHN'S UNIVERSITY   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ABCG2 pump; Tyrosine kinase inhibitors

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; MITOXANTRONE; OSI 930; PHENYL GROUP; PROTEIN TYROSINE KINASE INHIBITOR; PYRIDINE DERIVATIVE; STEM CELL FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CYTOTOXICITY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; STRUCTURE ACTIVITY RELATION;

EID: 80255129213     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.08.070     Document Type: Article

References (22)

1. Pytel, D.; Sliwinski, T.; Poplawski, T.; Ferriola, D.; Majsterek, I. Anti-Cancer Agents Med. Chem. 2009, 9, 66.
2. Roskoski, R., Jr. Biochem. Biophys. Res. Commun. 2005, 338, 1307.
3. Ribatti, D. Cancer Treat. Rev. 2011, 37, 344.
4. Tugues, S.; Koch, S.; Li, X.; Claesson-Welsh, L Mol. Aspects Med. 2011, 32, 88.
5. Liu, W.; Baer, M. R.; Bowman, M.J.; Pera, P.; Zheng, X.; Morgan, J.; Pandey, R A.; Oseroff, A. R. Clin. Cancer Res. 2007, 13, 2463.
6. Houghton, P. J.; Germain, G. S.; Harwood, F. C.; Schuetz, J. D.; Stewart, C. F.; Buchdunger, E.; Traxler, P. Cancer Res. 2004, 64, 2333.
7. Shi, Z.; Tiwari, A. K.; Shukla, S.; Robey, R. W.; Kim, I. W.; Parmar, S.; Bates, S. E.; Si, Q, S.; Goldblatt, C. S.; Abraham, I.; Fu, L. W.; Ambudkar, S. V.; Chen, Z. S. Biochem. Pharmacol. 2009, 77, 781.
8. Shi, Z.; Peng, X.X.; Kim, I. W.; Shukla, S.; Si, Q, S.; Robey, R. W.; Bates, S. E.; Shen, T., ; Ashby, C. R., Jr.; Fu, L W.; Ambudkar, S. V.; Chen, Z. S. Cancer Res. 2007, 67, 1012.
9. Dai, C. L.; Tiwari, A. K.; Wu, C. P.; Su, X. D.; Wang, S. R.; Liu, D. G.; Ashby, C. R., Jr.; Huang, Y.; Robey, R. W.; Liang, Y. J.; Chen, L. M.; Shi, C. J.; Ambudkar, S. V.; Chen, Z. S.; Fu, L. W. Cancer Res. 2008, 68, 7905.
10. Zhong, H.; Bowen, J. P. Curr. Med. Chem. 2007, 7, 1379.
11. Thomas, A. P.; Hennequin, L F. A.; Johnstone, C.; Stokes, E. S. E.; Lohmann, J.-J. M.; Clayton, E. WO9813354, 1998.
12. Bloxham, J. et al. United States Patent Application, July 2005.
13. Vetelino, M. G.; Coe, J. W. Tetrahedron Lett. 1994, 35, 219.
14. Panfilov, A. V.; Markovich, Y. D.; Zhirov, A. A.; Ivashev, I. P.; Kirsanpv, A. T.; Kondrat'ev, V. B. Pharm. Chem. J. 2000, 34, 371.
15. Reddy, P. S.; Kanjilal, S.; Sunitha, S.; Prasad, R. B. N. Tetrahedron Lett. 2007, 48, 8807.
16. Azizi, N.; Akbari, E.; Amiri, A K.; Saidi, M. R Tetrahedron Lett. 2008, 43, 6682.
17. Gowda, S.; Kempe Gowda, B. K.; Channe Gowda, D. Synth. Commun. 2003, 33, 281
18. Adams, R.; Cohen, F. L; Rees, O. W.J. Am. Chem. Soc. 1927, 43, 1093.
19. Korlipara, V. L; Takemori, A. E.; Portoghese, P. S. J. Med. Chem. 1995, 38, 1337.
20. Davis, R D.; Nelson, W. L.J. Med. Chem. 1995, 38, 570.
21. Ma, H.; Deacon, S.; Horiuchi, K. Expert Opin. Drug Disc. 2008, 3, 607.
22. Carmichael, J.; DeGraff, W.; Gazdar, A.; Minna, J.; Mitchell, J. Cancer Res. 1987, 47, 936.